mechanism of action of l carnitine The system and cancer metabolic plasticity Carnitine mechanism of action. VPA

Expression and co-induction of CYP1A1 and UGT1 * 6 in human lungs

The Science of Peptide Degradation: Why Temperature is the Enemy Lets get a bit more granular

Cenigaonandia-CampilloASerna-BlascoRGmez-OcaboLSolanes-CasadoSBaos-HerraizNPuerto-NevadoLet alVitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer

These include direct NLRP3 inhibitors (e.g., CY-09, MCC950, OLT1177/dapansutrile, oridonin, INF39, tranilast), blockade of pyroptosis or downstream effectors (e.g., disulfiram, dimethyl fumarate, maresin-1), and interference with adaptor or cytokine pathways such as ASC, NEK7, caspase-1, and IL-1 (e.g., lycorine, entrectinib, VX-765/X-740, canakinumab)